EMBL-EBI | Chemical Biology Resources | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:749608 - canakinumab
| ChEBI ID | CHEBI:749608 |
| ChEBI Name | canakinumab |
| Stars | |
| Last Modified | 29 June 2026 |
| Submitter | ChEMBL |
| Roles Classification |
|---|
| Biological Roles: | antimicrobial agent A substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans. antiviral agent A substance that destroys or inhibits replication of viruses. |
| Applications: | gout suppressant A drug that increases uric acid excretion by the kidney (uricosuric drug), decreases uric acid production (antihyperuricemic), or alleviates the pain and inflammation of acute attacks of gout. anti-inflammatory agent Any compound that has anti-inflammatory effects. antirheumatic drug A drug used to treat rheumatoid arthritis. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. antiatherosclerotic agent A cardiovascular drug that prevents atherosclerosis (a disease in which the inside of an artery narrows due to the build up of plaque). Compare with antiatherogenic agent. ophthalmology drug Any compound used for the treatment of eye conditions or eye diseases. hyperglycemic agent A drug which increases the blood glucose level. hypoglycemic agent A drug which lowers the blood glucose level. anti-anaemic agent A compound which increases either the number of red cells or the amount of haemoglobin in the blood. anti-arrhythmia drug A drug used for the treatment or prevention of cardiac arrhythmias. Anti-arrhythmia drugs may affect the polarisation-repolarisation phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibres. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| canakinumab (CHEBI:749608) has role anti-anaemic agent (CHEBI:75835) |
| canakinumab (CHEBI:749608) has role anti-arrhythmia drug (CHEBI:38070) |
| canakinumab (CHEBI:749608) has role anti-inflammatory agent (CHEBI:67079) |
| canakinumab (CHEBI:749608) has role antiatherosclerotic agent (CHEBI:145947) |
| canakinumab (CHEBI:749608) has role antimicrobial agent (CHEBI:33281) |
| canakinumab (CHEBI:749608) has role antineoplastic agent (CHEBI:35610) |
| canakinumab (CHEBI:749608) has role antirheumatic drug (CHEBI:35842) |
| canakinumab (CHEBI:749608) has role antiviral agent (CHEBI:22587) |
| canakinumab (CHEBI:749608) has role gout suppressant (CHEBI:35845) |
| canakinumab (CHEBI:749608) has role hyperglycemic agent (CHEBI:76916) |
| canakinumab (CHEBI:749608) has role hypoglycemic agent (CHEBI:35526) |
| canakinumab (CHEBI:749608) has role ophthalmology drug (CHEBI:66981) |
| canakinumab (CHEBI:749608) is a organic molecular entity (CHEBI:50860) |
| Synonyms | Source |
|---|---|
| ACZ-885 | ChEMBL |
| ACZ885 | ChEMBL |
| Canakinumab | ChEMBL |
| Brand Name | Source |
|---|---|
| Ilaris | ChEMBL |